News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,540 Results
Type
Article (41216)
Company Profile (264)
Press Release (686044)
Multimedia
Podcasts (88)
Webinars (20)
Section
Business (204798)
Career Advice (2028)
Deals (35560)
Drug Delivery (126)
Drug Development (81466)
Employer Resources (173)
FDA (16479)
Job Trends (14970)
News (346695)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2594)
Accelerated approval (43)
Adcomms (25)
Allergies (164)
Alliances (49584)
ALS (196)
Alzheimer's disease (1754)
Antibody-drug conjugate (ADC) (406)
Approvals (16819)
Artificial intelligence (612)
Autoimmune disease (235)
Automation (51)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (208)
Biotechnology (174)
Bladder cancer (179)
Brain cancer (67)
Breast cancer (700)
Cancer (5483)
Cardiovascular disease (452)
Career advice (1718)
Career pathing (41)
CAR-T (305)
CDC (54)
Celiac Disease (2)
Cell therapy (809)
Cervical cancer (43)
Clinical research (70375)
Collaboration (1963)
Company closure (4)
Compensation (1311)
Complete response letters (74)
COVID-19 (2731)
CRISPR (100)
C-suite (1025)
Cystic fibrosis (149)
Data (7270)
Decentralized trials (3)
Denatured (26)
Depression (154)
Dermatology (70)
Diabetes (553)
Diagnostics (6865)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (302)
Drug pricing (195)
Drug shortages (31)
Duchenne muscular dystrophy (267)
Earnings (91162)
Editorial (62)
Employer branding (21)
Employer resources (152)
Events (118670)
Executive appointments (1047)
FDA (19988)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1649)
Gene editing (214)
Generative AI (54)
Gene therapy (659)
GLP-1 (1026)
Government (4708)
Grass and pollen (6)
Guidances (401)
Healthcare (18962)
HIV (76)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (276)
Immuno-oncology (85)
Indications (164)
Infectious disease (3059)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (277)
Interviews (316)
IPO (16653)
IRA (50)
Job creations (3647)
Job search strategy (1430)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (556)
Leadership (35)
Legal (7951)
Liver cancer (98)
Longevity (29)
Lung cancer (734)
Lymphoma (411)
Machine learning (54)
Management (59)
Manufacturing (955)
MASH (178)
Medical device (13877)
Medtech (13959)
Mergers & acquisitions (20091)
Metabolic disorders (1427)
mRNA (181)
Multiple sclerosis (178)
NASH (17)
Neurodegenerative disease (386)
Neuropsychiatric disorders (97)
Neuroscience (3176)
Neurotech (1)
NextGen: Class of 2026 (6524)
Non-profit (4530)
Now hiring (74)
Obesity (673)
Opinion (280)
Ovarian cancer (197)
Pain (238)
Pancreatic cancer (265)
Parkinson's disease (346)
Partnered (33)
Patents (562)
Patient recruitment (617)
Peanut (60)
People (59370)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21933)
Phase 2 (30988)
Phase 3 (23067)
Pipeline (7466)
Policy (306)
Postmarket research (2566)
Preclinical (9326)
Press Release (64)
Prostate cancer (282)
Psychedelics (49)
Radiopharmaceuticals (311)
Rare diseases (1003)
Real estate (5961)
Recruiting (70)
Regulatory (25086)
Reports (54)
Research institute (2408)
Resumes & cover letters (353)
Rett syndrome (34)
RNA editing (18)
RSV (88)
Schizophrenia (167)
Series A (271)
Series B (205)
Service/supplier (11)
Sickle cell disease (107)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3629)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (60)
Vaccines (1067)
Venture capital (99)
Weight loss (431)
Women's health (114)
Worklife (20)
Date
Today (97)
Last 7 days (661)
Last 30 days (2451)
Last 365 days (30156)
2026 (9191)
2025 (30174)
2024 (35214)
2023 (40076)
2022 (51175)
2021 (55712)
2020 (54087)
2019 (46545)
2018 (35026)
2017 (32113)
2016 (31482)
2015 (37558)
2014 (31322)
2013 (26349)
2012 (28573)
2011 (29273)
2010 (27332)
Location
Africa (738)
Alabama (91)
Alaska (7)
Arizona (337)
Arkansas (14)
Asia (39522)
Australia (6473)
California (12498)
Canada (3587)
China (1262)
Colorado (536)
Connecticut (541)
Delaware (375)
Europe (85396)
Florida (1882)
Georgia (403)
Hawaii (3)
Idaho (62)
Illinois (996)
India (85)
Indiana (575)
Iowa (22)
Japan (504)
Kansas (129)
Kentucky (46)
Louisiana (38)
Maine (75)
Maryland (1507)
Massachusetts (8929)
Michigan (349)
Minnesota (685)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3324)
New Mexico (28)
New York (3293)
North Carolina (1582)
North Dakota (8)
Northern California (6203)
Ohio (373)
Oklahoma (23)
Oregon (41)
Pennsylvania (2529)
Puerto Rico (28)
Rhode Island (50)
South America (1112)
South Carolina (82)
South Dakota (2)
Southern California (4920)
Tennessee (201)
Texas (1973)
United States (44264)
Utah (376)
Vermont (1)
Virginia (295)
Washington D.C. (80)
Washington State (1003)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
727,540 Results for "beckman coulter inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes
April 13, 2026
·
8 min read
Press Releases
Beckman Coulter Diagnostics Selects Innovaccer Gravity™ as AI and Data Platform for Clinical Laboratory Operations Modernization
March 9, 2026
·
3 min read
Press Releases
Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows
November 13, 2025
·
4 min read
Press Releases
Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research
September 11, 2025
·
6 min read
Policy
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Beckman Coulter, a global leader in clinical diagnostics, announced U.S. Food and Drug Administration clearance of its Access NT-proBNP assay for the assessment of heart failure in less than 11 minutes on the Beckman Coulter DxI 9000 Immunoassay Analyzer*.
May 29, 2024
·
3 min read
Business
Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced expansion of their host immune response diagnostics partnership.
May 7, 2024
·
5 min read
Business
Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President
Beckman Coulter Diagnostics announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.
February 6, 2024
·
3 min read
Business
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics - March 12, 2024
Beckman Coulter Diagnostics today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced , ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases, that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.
April 16, 2024
·
4 min read
Biotech Beach
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
1 of 72,754
Next
